Cited by 53Neuroinflammation and Neurodegeneration MechanismsAmyotrophic Lateral Sclerosis ResearchGut microbiota and health

The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis

Open access
Cox, Laura M., Calcagno, Narghes, Gauthier, Christian, Madore, Charlotte, Butovsky, Oleg, Weiner, Howard L.·2022·Microbiome

Abstract

Background: The gut microbiota can affect neurologic disease by shaping microglia, the primary immune cell in the central nervous system (CNS). While antibiotics improve models of Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and the C9orf72 model of amyotrophic lateral sclerosis (ALS), antibiotics worsen disease progression the in SOD1 G93A model of ALS. In ALS, microglia transition from a homeostatic to a neurodegenerative (MGnD) phenotype and contribute to disease pathogenesis, but whether this switch can be affected by the microbiota has not been investigated. Results: In this short report , we found that a low-dose antibiotic treatment worsened motor function and decreased survival in the SOD1 mice, which is consistent with studies using high-dose antibiotics. We also found that co-housing SOD1 mice with wildtype mice had no effect on disease progression. We investigated changes in the microbiome and found that antibiotics reduced Akkermansia and butyrate-producing bacteria, which may be beneficial in ALS, and cohousing had little effect on the microbiome. To investigate changes in CNS resident immune cells, we sorted spinal cord microglia and found that antibiotics downregulated homeostatic genes and increased neurodegenerative disease genes in SOD1 mice. Furthermore, antibiotic-induced changes in microglia preceded changes in motor function, suggesting that this may be contributing to disease progression. Conclusions: Our findings suggest that the microbiota play a protective role in the SOD1 model of ALS by restraining MGnD microglia, which is opposite to other neurologic disease models, and sheds new light on the importance of disease-specific interactions between microbiota and microglia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40168-022-01232-z

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Antibiotic-induced dysbiosis worsens disease progression in SOD1G93A mice by downregulating homeostatic microglial genes and upregulating MGnD signatures in the spinal cord.

    “In addition, antibiotic-induced dysbiosis markedly worsened disease progression in SOD1G93A mice by downregulating homeostatic microglial genes and upregulating MGnD signatures in the spinal cord.229”
  • After antibiotic treatment, homeostatic genes were downregulated and neurodegenerative genes increased in microglia, and the microglia signature change preceded changes in motor function.

    “There was a downregulation of homeostatic genes and an increase in neurodegenerative genes in microglia after antibiotic treatment, and the microglia signature change preceded changes in motor function.359”
  • Antibiotic administration to SOD1 mice altered gut microbiota composition, weakened motor function, and caused death.

    “Antibiotic administration to SOD1 mice altered gut microbiota composition, weakened motor function, and caused death in the SOD1 mice.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cox, L. M., Calcagno, N., Gauthier, C., Madore, C., Butovsky, O., & Weiner, H. L.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Weiner, Howard L.
Venue
Microbiome
Published
2022-03-11
Volume
10
Issue
1
Pages
47-47
ISSN
2049-2618 (ISSN-L)
OpenAlex
W4220793283
Cited by
53
References
65
Citations by year
2026: 14 · 2025: 10 · 2024: 14 · 2023: 10 · 2022: 5
FWCI
3.52
Type
journal article
Language
en
Open access
Locations
  • Microbiome (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion, cc-by)
Funders
  • National Institute of Neurological Disorders and Stroke (R01NS115951, R01NS088137)
  • Brigham Research Institute (NextGen Award)
  • National Institute on Aging (R01AG051812, R01AG054672)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
gut microbiota, amyotrophic lateral sclerosis, microglia, neurodegeneration, SOD1 G93A mice, antibiotic therapy, Akkermansia, butyrate-producing bacteria, cohousing, motor function, neuroinflammation, microbiota-gut-brain axis
MeSH terms
Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Anti-Bacterial Agents, Disease Models, Animal, Mice, Transgenic, Superoxide Dismutase, Microglia, Disease Progression, Neurodegenerative Diseases, Mice, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review